Zhejiang Haisen Pharmaceutical Co Ltd Sustainability Reports
The company specializes in the research, development, production, and sales of chemical active pharmaceutical ingredients (APIs) and pharmaceutical intermediates. Its product portfolio primarily serves gastrointestinal, antipyretic, analgesic, and cardiovascular therapeutic areas.
Sector: Manufacturing
Country: China
Exchange: Shenzhen Stock Exchange
FIGI: BBG001TZGHT2
2 reports from 2023 to 2025